Navigation Links
Tech Award Recognizes Vocantas for Commercialization Partnership, Development of World-leading Chronic Disease Management Solution
Date:4/17/2009

OTTAWA, April 17 /PRNewswire/ - Vocantas Inc., a developer of automated outreach solutions, was honoured to receive the Technology Commercialization Partnership award at the 14th annual OCRI Awards. The award was presented to Vocantas for the collective research and development that resulted in the successful implementation of its automated solution for chronic disease management, CallAssure.

Each year, OCRI (Ottawa Centre for Research and Innovation) presents the Technology Commercialization Partnership award to a company for its collaborative effort with a researcher (or a team of researchers) that has led to successful commercialization of a cutting-edge technology.

This year's win by Vocantas was based on recent work with numerous healthcare professionals and The Ottawa Hospital Thrombosis Program. The joint effort between Vocantas and its research partners has brought forth an innovative technology to improve communication between patients and caregivers, and to more efficiently manage chronic disease.

"I would like to thank all of the researchers and healthcare professionals at The Ottawa Hospital who have helped us with the development and commercialization of CallAssure," said Gary T. Hannah, president and CEO of Vocantas, upon accepting the award. "We look forward to a lasting partnership."

CallAssure is Vocantas' automated patient monitoring system that integrates dose technology with information regarding upcoming tests and notifications of any changes to the patient's care plan. Vocantas is now promoting its CallAssure product with confidence to hospitals and clinics across North America to help them better manage patients with chronic conditions.

The OCRI awards celebrate excellence in the areas of research, technology, entrepreneurship, leadership, partnership and student accomplishment. Over 60 nominations for the nine categories were received from Ottawa's business and education community last December and were reviewed by the Society of Collaborative Opportunities and Advancement of Professionals (SCOAP).

CallAssure is a registered trademark of Vocantas Inc. The names of other companies or products mentioned herein may be the trademarks of their respective owners.

About Vocantas

Vocantas is a developer of interactive voice response systems (IVRS) that use advanced computer telephony and speech technology to provide its customers with cost-effective customer outreach solutions. The company's easy-to-use, turn-key solutions offer customizable core features and optional enhancements that integrate seamlessly with existing systems. Its products have particular application in the healthcare, education, utilities and customer service environments where they have been proven to increase efficiencies while minimizing operational costs. For more information, please visit www.vocantas.com.


'/>"/>
SOURCE VOCANTAS
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Precyse Solutions Names 2008 Marquee Client Award Winners
2. Wellesse Receives Corporate Sponsor of the Year Award From the Arthritis Foundations Pacific Northwest Chapter
3. Zultys Inc. Receives 2009 NGN Leadership Award from NGN Magazine
4. Missouri Hospice & Palliative Care Association Recognizes Volunteers in Hospice With Heart of Hospice Awards Luncheon
5. One Family to Honor Sue Beaton with Founders Award
6. BIDMC scientists receive creativity awards from Prostate Cancer Foundation
7. Milton resident receives the Helen B. Spaulding Community Conscience Award
8. First Bringing Hope To Life Award to Howard Pete Love
9. Three Medical Centers Awarded Funds to Study Generation of Cardiac Muscle Cells
10. Smith & Wesson Security Services Wins Top Honors at SAMMY awards
11. DaVita Dietitian Receives 2009 National Kidney Foundation Award for Outstanding Contributions to Renal Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... Groth Family Insurance, a ... Richland, is initiating a charity drive to support the family of Cindy Hendrickson, ... collision. , On October 29th of this year, Cindy Hendrickson swerved to ...
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, the ... the grand opening of the Sober College Robert Pfeifer Memorial Learning Center at ... 2-3, and was attended by an overwhelming amount of alumni, family, colleagues and ...
(Date:12/9/2016)... ... ... "I had a terrible time trying to get my grandson to use his ... had a more child-friendly design, then children would be more likely to look forward ... avoid the need to deliver medication via a nebulizer mask. The design will not ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ ... announced the first national #QuackGivesBack campaign which supported local breast cancer organizations during ... franchise-wide Quack Gives Back initiative, and we’re very pleased with the ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for ... In Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues ... implant and prosthetic market in the U.S. is projected to reach $6.4 billion in ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized by ... Workplaces National Standard. To learn more about Diplomat,s ... ... ... administered by WorkplaceDynamics, LLC, a research firm specializing in organizational health ...
(Date:12/8/2016)... Connecticut , 8 de dezembro de 2016  A Mederi Therapeutics ... terapia Stretta, um tratamento não cirúrgico para a doença do refluxo gastroesofágico (DRGE). ... ... Live Stretta procedure performed and ... of Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  A new ... reports that the use of opioid therapy to treat ... increase the likelihood of more harmful consequences, including death. ... , M.D., and Zankhana Mehta , M.D., authored ... research on chronic opioid therapy. The study was published ...
Breaking Medicine Technology: